M

MITech Co Ltd
KOSDAQ:179290

Watchlist Manager
MITech Co Ltd
KOSDAQ:179290
Watchlist
Price: 7 230 KRW Market Closed
Market Cap: 234B KRW

Operating Margin

30.2%
Current
Declining
by 2.8%
vs 3-y average of 33%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
30.2%
=
Operating Income
₩18.8B
/
Revenue
₩62.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
30.2%
=
Operating Income
₩18.8B
/
Revenue
₩62.2B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
MITech Co Ltd
KOSDAQ:179290
234B KRW
Loading...
US
Abbott Laboratories
NYSE:ABT
188.9B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD
Loading...
US
Stryker Corp
NYSE:SYK
137.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.3B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.3B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.3B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.3B USD
Loading...

Market Distribution

Higher than 95% of companies in Korea
Percentile
95th
Based on 2 615 companies
95th percentile
30.2%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

MITech Co Ltd
Glance View

Market Cap
234B KRW
Industry
Health Care

M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 157 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
13 744.46 KRW
Undervaluation 47%
Intrinsic Value
Price
M
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
30.2%
=
Operating Income
₩18.8B
/
Revenue
₩62.2B
What is MITech Co Ltd's current Operating Margin?

The current Operating Margin for MITech Co Ltd is 30.2%, which is below its 3-year median of 33%.

How has Operating Margin changed over time?

Over the last 3 years, MITech Co Ltd’s Operating Margin has increased from 27% to 30.2%. During this period, it reached a low of 27% on Aug 30, 2022 and a high of 37.8% on Dec 31, 2022.

Back to Top